Farkouh, Michael E.

Strategies for Multivessel Revascularization in Patients with Diabetes

Farkouh, M. E., Domanski, M., Sleeper, L. A., Siami, F. S., Dangas, G., Mack, M., Yang, M., Cohen, D. J., Rosenberg, Y., Solomon, S. D., et al. (2012) · New England Journal of Medicine

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 1,922

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 941

Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data

Head, S. J., Milojevic, M., Daemen, J., Ahn, J.-M., Boersma, E., Christiansen, E. H., Domanski, M. J., Farkouh, M. E., Flather, M., Fuster, V., et al. (2018) · The Lancet

Coronary Interventions and DiagnosticsCardiac and Coronary Surgery Techniques

Cited by 734

Inflammation, Immunity, and Infection in Atherothrombosis

Libby, P., Loscalzo, J., Ridker, P. M., Farkouh, M. E., Hsue, P. Y., Fuster, V., Hasan, A. A., & Amar, S. (2018) · Journal of the American College of Cardiology

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 548

Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options

Aneja, A., Tang, W. H. W., Bansilal, S., Garcia, M. J., & Farkouh, M. E. (2008) · The American Journal of Medicine

Cardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling

Cited by 482

Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

Domanski, M. J., Tian, X., Wu, C. O., Reis, J. P., Dey, A. K., Gu, Y., Zhao, L., Bae, S., Liu, K., Hasan, A. A., et al. (2020) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 411

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

Greenberg, J. D., Kremer, J. M., Curtis, J. R., Hochberg, M. C., Reed, G., Tsao, P., Farkouh, M. E., Nasir, A., Setoguchi, S., & Solomon, D. H. (2011) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesInflammatory mediators and NSAID effects

Cited by 350

A Polypill Strategy to Improve Adherence

Castellano, J. M., Sanz, G., Peñalvo, J. L., Bansilal, S., Fernández-Ortiz, A., Alvarez, L., Guzmán, L., Linares, J. C., García, F., D’Aniello, F., et al. (2014) · Journal of the American College of Cardiology

Medication Adherence and ComplianceAcute Myocardial Infarction Research

Cited by 349

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes

Farkouh, M. E., Domanski, M., Dangas, G. D., Godoy, L. C., Mack, M. J., Siami, F. S., Hamza, T. H., Shah, B., Stefanini, G. G., Sidhu, M. S., et al. (2019) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac and Coronary Surgery Techniques

Cited by 268

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

Udell, J. A., Cavender, M. A., Bhatt, D. L., Chatterjee, S., Farkouh, M. E., & Scirica, B. M. (2015) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 254

Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers

Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Disease and Adiposity

Cited by 243

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

Ghosh-Swaby, O. R., Goodman, S. G., Leiter, L. A., Cheng, A., Connelly, K. A., Fitchett, D., Jüni, P., Farkouh, M. E., & Udell, J. A. (2020) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 159

Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies

Lawler, P. R., Kotrri, G., Koh, M., Goodman, S. G., Farkouh, M. E., Lee, D. S., Austin, P. C., Udell, J. A., & Ko, D. T. (2020) · European Heart Journal

Lipoproteins and Cardiovascular HealthFatty Acid Research and Health

Cited by 113

Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps

Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk Factors

Cited by 113

SYNTAX Score and Long-Term Outcomes

Ikeno, F., Brooks, M. M., Nakagawa, K., Kim, M.-K., Kaneda, H., Mitsutake, Y., Vlachos, H. A., Schwartz, L., Frye, R. L., Kelsey, S. F., et al. (2017) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 85

Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease

Mancini, G. B. J., Farkouh, M. E., Brooks, M. M., Chaitman, B. R., Boden, W. E., Vlachos, H., Hartigan, P. M., Siami, F. S., Sidhu, M. S., Bittner, V., et al. (2016) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 64

Statins and contrast-induced acute kidney injury with coronary angiography

Gandhi, S., Mosleh, W., Abdel-Qadir, H., & Farkouh, M. E. (2014) · The American Journal of Medicine

Acute Kidney Injury ResearchChronic Kidney Disease and Diabetes

Cited by 62

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial

Esper, R. B., Farkouh, M. E., Ribeiro, E. E., Hueb, W., Domanski, M., Hamza, T. H., Siami, F. S., Godoy, L. C., Mathew, V., French, J., et al. (2018) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 61

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis

Lok, C. E., Farkouh, M., Hemmelgarn, B. R., Moist, L. M., Polkinghorne, K. R., Tomlinson, G., Tam, P., Tonelli, M., & Udell, J. A. (2026) · New England Journal of Medicine

Fatty Acid Research and HealthDialysis and Renal Disease Management

Cited by 60

Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes

Farkouh, M. E., Sidhu, M. S., Brooks, M. M., Vlachos, H., Boden, W. E., Frye, R. L., Hartigan, P., Siami, F. S., Bittner, V. A., Chaitman, B. R., et al. (2019) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsChronic Kidney Disease and Diabetes

Cited by 58

Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease

Gamboa, C. M., Safford, M. M., Levitan, E. B., Mann, D. M., Yun, H., Glasser, S. P., Woolley, J. M., Robert, R., Farkouh, M., & Muntner, P. (2014) · The American Journal of the Medical Sciences

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 50

PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)

Mefford, M. T., Rosenson, R. S., Cushman, M., Farkouh, M. E., McClure, L. A., Wadley, V. G., Irvin, M. R., Bittner, V., Safford, M. M., Somaratne, R., et al. (2018) · Circulation

Lipoproteins and Cardiovascular HealthDementia and Cognitive Impairment Research

Cited by 44

Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort

Sharma, D., Gotlieb, N., Farkouh, M. E., Patel, K., Xu, W., & Bhat, M. (2022) · Journal of the American Heart Association

Liver Disease Diagnosis and TreatmentArtificial Intelligence in Healthcare

Cited by 36